| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2023 |
4
| CROSS HERB (CFO) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 550,000 options to buy
@ $0.78, valued at
$429k
|
|
| 09/26/2023 |
3
| CROSS HERB (CFO) has filed a Form 3 on Jasper Therapeutics, Inc. |
| 06/08/2023 |
4
| Kapoor Vishal (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 47,000 options to buy
@ $1.6, valued at
$75.2k
|
|
| 06/08/2023 |
4
| Klein Lawrence Otto (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 47,000 options to buy
@ $1.6, valued at
$75.2k
|
|
| 06/08/2023 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 47,000 options to buy
@ $1.6, valued at
$75.2k
|
|
| 06/08/2023 |
4
| Shizuru Judith Anne (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 47,000 options to buy
@ $1.6, valued at
$75.2k
|
|
| 06/08/2023 |
4
| Nolet Chris (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 47,000 options to buy
@ $1.6, valued at
$75.2k
|
|
| 06/08/2023 |
4
| Lis William (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 47,000 options to buy
@ $1.6, valued at
$75.2k
|
|
| 06/08/2023 |
4
| French Anna Louise (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 47,000 options to buy
@ $1.6, valued at
$75.2k
|
|
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| MARTELL RON (President, CEO and Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 500,000 options to buy
@ $1.87, valued at
$935k
|
|
| 02/27/2023 |
3/A
| Kapoor Vishal (Director) has filed a Form 3/A on Jasper Therapeutics, Inc. |
| 02/03/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2023 |
4
| ROCHE HOLDING LTD (10% Owner) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Sold 75,000 shares
@ $1.89, valued at
$141.8k
|
|
| 10/13/2022 |
4
| MARTELL RON (President, CEO and Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 506,250 shares
@ $0 |
|
| 10/13/2022 |
4
| Klein Lawrence Otto (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 24,500 shares
@ $0 |
|
| 10/13/2022 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 30,250 shares
@ $0 |
|
| 10/13/2022 |
4
| Shizuru Judith Anne (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 29,500 shares
@ $0 |
|
| 10/13/2022 |
4
| Mahal Jeetinder Singh (See Remarks) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 214,722 shares
@ $0 |
|
| 10/13/2022 |
4
| Nolet Chris (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 32,500 shares
@ $0 |
|
| 10/13/2022 |
4
| Lis William (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 29,500 shares
@ $0 |
|
| 10/13/2022 |
4
| French Anna Louise (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 30,750 shares
@ $0 |
|
| 08/11/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|